Cargando…

Clinical relevance of androgen receptor alterations in prostate cancer

Prostate cancer (PC) remains a leading cause of cancer-related deaths among men worldwide, despite continuously improved treatment strategies. Patients with metastatic disease are treated by androgen deprivation therapy (ADT) that with time results in the development of castration-resistant prostate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jernberg, Emma, Bergh, Anders, Wikström, Pernilla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640574/ https://www.ncbi.nlm.nih.gov/pubmed/29030409 http://dx.doi.org/10.1530/EC-17-0118

Ejemplares similares

Characterization of Prostate Cancer Bone Metastases According to Expression Levels of Steroidogenic Enzymes and Androgen Receptor Splice Variants
por: Jernberg, Emma, et al.
Publicado: (2013)

Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor Activity
por: Nordstrand, Annika, et al.
Publicado: (2018)

A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer
por: Ylitalo, Erik Bovinder, et al.
Publicado: (2021)

Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival
por: Hörnberg, Emma, et al.
Publicado: (2011)

Metabolomic profiles of intact tissues reflect clinically relevant prostate cancer subtypes
por: Dudka, Ilona, et al.
Publicado: (2023)

Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti‐androgens
por: Ylitalo, Erik Bovinder, et al.
Publicado: (2019)

Extratumoral Heme Oxygenase-1 (HO-1) Expressing Macrophages Likely Promote Primary and Metastatic Prostate Tumor Growth
por: Halin Bergström, Sofia, et al.
Publicado: (2016)

High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting
por: Nilsson, Maria, et al.
Publicado: (2015)

Epithelial and Stromal Characteristics of Primary Tumors Predict the Bone Metastatic Subtype of Prostate Cancer and Patient Survival after Androgen-Deprivation Therapy
por: Wikström, Pernilla, et al.
Publicado: (2022)

Clinical and biological relevance of the transcriptomic‐based prostate cancer metastasis subtypes MetA‐C
por: Thysell, Elin, et al.
Publicado: (2021)

Outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer
por: Crnalic, Sead, et al.
Publicado: (2012)

Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumor
por: Thysell, Elin, et al.
Publicado: (2019)

Extracellular Vesicles from Metastatic Rat Prostate Tumors Prime the Normal Prostate Tissue to Facilitate Tumor Growth
por: Halin Bergström, Sofia, et al.
Publicado: (2016)

Inhibition of the insulin-like growth factor-1 receptor potentiates acute effects of castration in a rat model for prostate cancer growth in bone
por: Nordstrand, Annika, et al.
Publicado: (2017)

Plasma Androgen Receptor in Prostate Cancer
por: Conteduca, Vincenza, et al.
Publicado: (2019)

Biological and Clinical Significance of Androgens and Androgen Receptor in Prostate Cancer
por: Koochekpour, Shahriar
Publicado: (2014)

Metabolomic Characterization of Human Prostate Cancer Bone Metastases Reveals Increased Levels of Cholesterol
por: Thysell, Elin, et al.
Publicado: (2010)

The Androgen Receptor and VEGF: Mechanisms of Androgen-Regulated Angiogenesis in Prostate Cancer
por: Eisermann, Kurtis, et al.
Publicado: (2017)

High‐grade tumours promote growth of other less‐malignant tumours in the same prostate
por: Halin Bergström, Sofia, et al.
Publicado: (2021)

Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
por: Chuu, Chih-Pin, et al.
Publicado: (2011)

Response to Androgens and Androgen Receptor Antagonists in the Presence of Cytokines in Prostate Cancer
por: Culig, Zoran
Publicado: (2021)

A Novel Radiographic Pattern Related to Poor Prognosis in Patients with Prostate Cancer with Metastatic Spinal Cord Compression
por: Wänman, Johan, et al.
Publicado: (2022)

High Caveolin-1 Expression in Tumor Stroma Is Associated with a Favourable Outcome in Prostate Cancer Patients Managed by Watchful Waiting
por: Hammarsten, Peter, et al.
Publicado: (2016)

Posttranslational Modification of the Androgen Receptor in Prostate Cancer
por: van der Steen, Travis, et al.
Publicado: (2013)

Splice Variants of Androgen Receptor and Prostate Cancer
por: Caffo, Orazio, et al.
Publicado: (2016)

Regulation of androgen receptor variants in prostate cancer
por: Zhu, Yezi, et al.
Publicado: (2020)

Androgen receptor co-regulation in prostate cancer
por: Senapati, Dhirodatta, et al.
Publicado: (2020)

Androgen Receptor-Mediated Transcription in Prostate Cancer
por: Özturan, Doğancan, et al.
Publicado: (2022)

Posttranslational regulation of androgen dependent and independent androgen receptor activities in prostate cancer
por: Wen, Simeng, et al.
Publicado: (2020)

Metabolic Roles of Androgen Receptor and Tip60 in Androgen-Dependent Prostate Cancer
por: Tan, Kah Ni, et al.
Publicado: (2020)

Biomarker-Based Targeting of the Androgen-Androgen Receptor Axis in Advanced Prostate Cancer
por: Kohli, Manish, et al.
Publicado: (2012)

Stromal Androgen Receptor in Prostate Cancer Development and Progression
por: Leach, Damien A., et al.
Publicado: (2017)

Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies
por: Jacob, Aasems, et al.
Publicado: (2021)

Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes
por: Jillson, Lauren K., et al.
Publicado: (2021)

Suppressive Role of Androgen/Androgen Receptor Signaling via Chemokines on Prostate Cancer Cells
por: Izumi, Kouji, et al.
Publicado: (2019)

Secreted Factors from Colorectal and Prostate Cancer Cells Skew the Immune Response in Opposite Directions
por: Lundholm, Marie, et al.
Publicado: (2015)

Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications
por: Aurilio, Gaetano, et al.
Publicado: (2020)

Inhibition of the Insulin-Like Growth Factor-1 Receptor Enhances Effects of Simvastatin on Prostate Cancer Cells in Co-Culture with Bone
por: Nordstrand, Annika, et al.
Publicado: (2013)

Androgen receptor signaling in prostate cancer development and progression
por: Lonergan, Peter E, et al.
Publicado: (2011)

Role of Androgen Receptor in Prostate Cancer: A Review
por: Fujita, Kazutoshi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_126sidqksd6d2qbocm74mt0ifn